Evidence map›Paper›PMID 39582753›Full record

ArticleBiochemistry and biophysics reports2024

A pan-cancer analysis of the oncogenic function of HMGB1 in human tumors.

Hui-Min Yang, Xiang-Ning Zhao, Xiao-Ling Li, Xi Wang, Yu Pu, Dong-Kai Wei, Zhe Li

Abstract read
In one paragraph

Article in Biochemistry and biophysics reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hui-Min YangShanghai Singlera Medical Laboratory, 1rst Floor, No. 20 Building, 500 Furonghua Road, Pudong New District, Shanghai, China.
Xiang-Ning ZhaoDepartment of Surgical Oncology, Shanghai Mengchao Cancer Hospital, 118 Qianyang Road, Jiading District, Shanghai, China.
Xiao-Ling LiSuzhou Func Biotech Inc, Suzhou, Jiangsu, China.
Xi WangSuzhou Func Biotech Inc, Suzhou, Jiangsu, China.
Yu PuSuzhou Func Biotech Inc, Suzhou, Jiangsu, China.
Dong-Kai WeiSuzhou Func Biotech Inc, Suzhou, Jiangsu, China.
Zhe LiDepartment of Breast Surgery, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, 528 Zhangheng Road, Pudong New District, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Although high mobility group box protein 1 ( Methods: This investigation employed The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases to examine Results: There was a notable elevation of Conclusion: This pan-cancer study of

Indexed as

CancerHMGB1Immune cell infiltrationMutationPrognostic

Identifiers

PMID39582753
PMCPMC11584604

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.